Purpose: The carrier for the delivery of bone morphogenetic proteins(BMPs) should also serve as a scaffold for new bone growth. In addition, predictable bone formation in terms of the volume and shape should be guaranteed. This study evaluated the ectopic bone formation of recombinant human BMP-2(rhBMP-2) using a micro macroporous biphasic calcium phosphate (MBCP: mixture of β-TCP and HA) block as a carrier in a rat subcutaneous assay model. Materials and Methods: Subcutaneous pockets were created on the back of 40 male Sprague-Dawley rats. In the pockets, rhBMP-2/MBCP and MBCP alone were implanted. The blocks were evaluated by histological and histometric parameters after a healing interval of 2 weeks (each 10 rats; MBCP and rhBMP-2/MBCP) or 8 weeks (each 10 rats; MBCP and rhBMP-2/MBCP). Results: The shape and volume of the block was maintained stable over the healing period. No histological bone forming activity was observed in the MBCP alone sites after 2 weeks and there was minimal new bone formation at 8 weeks. In the rhBMP-2/MBCP sites, new bone formation was evident in the macropores of the block. The new bone area at 8 weeks was greater than at 2 weeks. There was a further increase in the quantity of new bone with the more advanced stage of remodeling. Conclusions: A MBCP block could serve as a carrier system for predictable bone tissue engineering using rhBMPs. KEY WORDS: rhBMP-2; biphasic calcium phosphate block; carrier; ectopic bone formation.
Introduction
Since Urist 1) demonstrated ectopic bone and cartilage formation after the intramuscular implantation of demineralized bone matrix in rats, which were later named as bone morphogenetic proteins(BMPs), several
BMPs have been shown to have significant osteoinductive activity [2] [3] [4] [5] [6] [7] [8] . It was reported that rhBMP itself is sufficient to induce bone formation. However, the rapid diffusion of the water-soluble protein rhBMP from the implant site will reduce its osteoinductive effect. Therefore, a carrier system for rhBMPs is essential [9] [10] [11] [12] .
The carrier for BMPs should serve as a scaffold for bone forming cells while providing space in which bone formation can occur, and resist soft tissue compression during the healing period 13) . For the clinically successful use of BMPs, the carrier should also be easy to manipulate, sterilize, and fabricate into the intended shape. It is also important that the shape and volume of newly formed bone be maintained. If these requirements of carrier are satisfied, predictable bone regeneration is possible with sufficient value to the tissue engineering side. There have been many rhBMP-2 using biphasic calcium phosphate block as a carrier induces new bone formation in a rat subcutaneous tissue studies on carriers [14] [15] [16] [17] , but no carriers have satisfied these requirements perfectly.
Micro macroporous biphasic calcium phosphate (MBCP) consists of an intimate mixture of 40% β -tricalcium phosphate(β -TCP) and 60% hydroxyapatite(HA) 18, 19) . Besides the well-documented osteoconductive effect [20] [21] [22] , the osteoinductive effect of the MBCP is recommended for use as an alternative or as an additive to autogenous bone for orthopedics, traumatology, odontology and dental applications [23] [24] [25] [26] [27] [28] . The porous structure, low resorption rate, favorable osteoconductivity and bioactive properties of MBCP can be utilized by rhBMPs carrier. The easy manipulation and producing the intended shape, particularly the block type, are additional merits of using this biomaterial. However, there has been little study on its use as a carrier for BMPs 29, 30) .
The subcutaneous tissue of a rat has poorer conditions than the muscle or bony site or the subcutaneous tissue of other animals [31] [32] [33] [34] . Therefore, success this region can indicate better success in other regions.
This study evaluated the ectopic bone formation of rhBMP-2 using a MBCP block as a carrier in a rat subcutaneous assay model. 
Materials and Methods

rhBMP-2 Implant Construction
Disc-shaped MBCP implants (Biomatlante Inc., Vigneux de Bretagne, France) (3mm height and 8mm diameter) were manufactured ( 
Histologic and Histometric Procedures
The animals were sacrificed by CO 2 asphyxiation at 2 and 8 weeks post-surgery. Block sections were removed and fixed in a 10% neutral buffered formalin solution for 10 days. Samples were decalcified by 5%
formic acid for 14 days and embedded in paraffin.
Serial sections 7um in thickness were prepared at intervals of 80um, stained with hematoxylin/eosin (H-E), and examined using a light microscope. The most central sections from each block were selected for histologic and histometric evaluation.
Computer-assisted histometric measurements were obtained using an automated image analysis system 
Statistical Analysis
Histometric recordings from the samples were used to calculate means and standard deviations (m±SD).
For comparisons between the two groups, a paired or unpaired t-test was used. The interactions between the healing times were examined using two-way analysis of variance. A p-value ＜0.01 was considered significant.
Results
Clinical observation
Wound healing was generally uneventful and there were no signs and symptoms of infection or in- (Fig. 2-B, D) . There was no evidence of cartilage formation ( Fig.   3-B, D) . 
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Discussion
The aim of this study was to evaluate the ectopic bone formation of rhBMP-2 using a MBCP block as a carrier in a rat subcutaneous assay model. Because In a previous study 13) using a similar method to this study, it was demonstrated that rhBMP-2, when im- MBCP consists of an intimate mixture of 40% β -TCP and 60% HA, and is obtained when a synthetic calcium deficient apatite is sintered at ≥700ﾟC. It is now available in blocks, particulates and as an injectable material in a polymer carrier 18, 19) . MBCP has excellent biocompatibility and bioactivity, which is related to its porous structure [20] [21] [22] . Micropores≤10μ m allow fluid circulation, leading to the dissolution and 29, 30) .
In this study, new bone formation in the macropores of the block was evident in the rhBMP-2/MBCP sites. The new bone area was greater at 8 weeks than at 2 weeks. The quantity of the new bone had increased further with the more advanced stage of remodeling. In addition, the total augmented area was stable during the healing period. In subcutaneous tissue of rats, this favorable results confirmed that the MBCP block is a good carrier system for tissue engineering using rhBMPs.
In conclusion, the use of the block type of MBCP as a carrier for rhBMP-2 is effective in inducing new bone formation. The new bone induced by the rhBMPs/MBCP block system was stable during the observed healing period. These results suggest that the MBCP block system can be used as a carrier system for tissue engineering using rhBMPs
